Resumen
Definição
História e exame físico
Principais fatores diagnósticos
- presença de fatores de risco
- parotidite
- história de vacinação perdida ou ausência ou possível falha da vacina (primária ou secundária)
Outros fatores diagnósticos
- sintomas constitucionais
- orquite
- ooforite
- meningite asséptica
- mastite
- encefalite
- surdez
Fatores de risco
- estado não vacinado
- imunossupressão
- profissional da saúde
- viajante internacional
- contato próximo com pessoas infectadas (estudantes universitários, prisioneiros, militares)
- falha da vacina
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- IgM salivar de caxumba
- reação em cadeia da polimerase via transcriptase reversa
Investigações a serem consideradas
- hemograma completo e diferencial
- imunoglobulina M (IgM) sérica de caxumba
- imunoglobulina G (IgG) sérica de caxumba
- amilase sérica
- cultura viral (LCR, saliva ou urina)
- punção lombar
- tomografia computadorizada (TC) do crânio
Algoritmo de tratamento
todos os pacientes
Colaboradores
Autores
David Elliman, MB BS, FRCPCH, FRCP, FFPH, DCH, BA (Open)
Consultant in Community Child Health
Great Ormond Street Hospital
London
UK
Declarações
DE is involved in expert legal work where those with parental responsibility disagree as to whether a child should be immunised.
Helen Bedford, PhD, FFPH, FRCPCH
Professor of Children's Health
UCL Institute of Child Health
London
UK
Declarações
HB declares that she has no competing interests.
Agradecimentos
Dr David Elliman and Professor Helen Bedford would like to gratefully acknowledge Dr Kristin Furfari, a previous contributor to this topic.
Declarações
KF declares that she has no competing interests.
Revisores
Ravi Ubriani, MD, FAAD
Assistant Professor of Clinical Dermatology
Columbia University
New York
NY
Declarações
RU declares that he has no competing interests.
Christopher D. Huston, MD
Assistant Professor of Medicine
Division of Infectious Diseases
University of Vermont College of Medicine
Burlington
VT
Declarações
CDH declares that he has no competing interests.
Kristine Macartney, MBBS, BMedSci, MD, FRACP
Deputy Director
National Centre for Immunisation Research and Surveillance
Postgraduate Fellow
Department Of Microbiology and Infectious Diseases
The Children’s Hospital
Westmead
New South Wales
Australia
Disclosures
KM declares that she has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
References
Key articles
Centers for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 5: travel-associated infections & diseases - mumps. May 2023 [internet publication].Full text
Di Pietrantonj C, Rivetti A, Marchione P, et al. Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database Syst Rev. 2021 Nov 22;11:CD004407.Full text Abstract
McLean HQ, Fiebelkorn AP, Temte JL, et al. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34.Full text Abstract
UK Health Security Agency. Mumps: the green book, chapter 23. Apr 2013 [internet publication].Full text
Centers for Disease Control and Prevention. Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2025. Nov 2024 [internet publication].Full text
Marin M, Marlow M, Moore KL, et al. Recommendation of the Advisory Committee on Immunization Practices for use of a third dose of mumps virus-containing vaccine in persons at increased risk for mumps during an outbreak. MMWR Morb Mortal Wkly Rep. 2018 Jan 12;67(1):33-8.Full text Abstract
Centers for Disease Control and Prevention. Recommended adult immunization schedule for ages 19 years or older, United States, 2025. Nov 2024 [internet publication].Full text
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Differentials
- Parainfluenza
- Vírus Coxsackie
- Infecção por vírus da imunodeficiência humana (HIV) aguda
More DifferentialsGuidelines
- Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2025
- Recommended adult immunization schedule for ages 19 years or older, United States, 2025
More GuidelinesPatient information
Sarampo, caxumba e rubéola: meu filho deve tomar a vacina tríplice viral?
More Patient information
Log in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer